1 Department of Dermatology, CHU Bordeaux, F-33000 Bordeaux, France.
2 Department of Dermatology, AP-HP, Henri Mondor Hospital, 94010 Créteil, France; University Paris Est Créteil EpiDermE, 94010 Créteil, France; French Cutaneous Lymphomas Study Group (GFELC), Paris, France.
3 Department of Hematology, University Hospital of Reims and UFR Médecine, 51100 Reims, France.
4 Department of Dermatology, CHU Bordeaux, F-33000 Bordeaux, France; French Cutaneous Lymphomas Study Group (GFELC), Paris, France; Bordeaux Institute of Oncology, BRIC U1312, INSERM, Translational Research on Oncodermatology and rare skin diseases, Univ. Bordeaux, F-33000 Bordeaux, France.
5 Department of Dermatology, CHU Bordeaux, F-33000 Bordeaux, France; French Cutaneous Lymphomas Study Group (GFELC), Paris, France; Bordeaux Institute of Oncology, BRIC U1312, INSERM, Translational Research on Oncodermatology and rare skin diseases, Univ. Bordeaux, F-33000 Bordeaux, France. Electronic address: [email protected].